Skip to main content

An Analyst Mistakes Checklist

The previous articles in this chapter catalogued specific, high-impact mistakes: wrong discount rates, bad peer sets, misaligned incentives, falling in love with a stock. Each is a potential disaster that can hide inside what looks like rigorous analysis.

But identifying single failures isn't enough. The best analysts use systematic frameworks—checklists—to catch errors before they compound. A mistake that slips through one filter can be caught at the next.

This article is a practical checklist covering all phases of fundamental analysis: business model assessment, competitive positioning, financial analysis, valuation, and behavioral discipline. Use it as a gate before publishing a research note, presenting an investment committee pitch, or deploying capital.

Quick definition: A mistakes checklist is a systematic filter applied across all major analytical steps to catch common errors of analysis, process, and psychology before they produce a faulty investment decision.

Key Takeaways​

  • Checklists don't eliminate errors, but they reduce their frequency and severity by forcing systematic attention to categories of risk.
  • The most consequential mistakes often aren't about individual calculations; they're about missing categories of risk (competitive, financial, behavioral, macro).
  • A good checklist should be used before publication or deployment, not after losses. It's a gate, not a post-mortem.
  • Checklists work best when tailored to your specific errors: if you've historically been bullish on turnarounds, add more rigor to business model checks; if you've been blind to leverage, add deeper solvency filters.
  • The final gate should always be a behavioral check: Are you emotionally attached to this view? What evidence would falsify it? Can you argue the opposite case?

Mermaid: The Three-Gate Checklist Framework​

Gate 1: Business and Competitive Analysis Checklist​

Business Model

  • Does the company have a defensible competitive moat? (Patents, switching costs, scale, brand, cost advantage, network effects?)
  • Is the moat durable, or is it eroding? (Look at market share trends, customer retention, competitor moves.)
  • What percent of revenue comes from recurring, recurring-like, or transactional streams? Are you comfortable with that mix?
  • What is the capital intensity of the business (capex as % of revenue)? Is it consistent with industry norms, or is there a reason for divergence?
  • What is the customer acquisition cost? The lifetime value? Is CAC payback sustainable?
  • Does the company have pricing power? (Can margins expand if costs rise, or will volumes collapse?)
  • Are there single customers or suppliers with >15% concentration? If yes, is the relationship durable, or is there exit risk?

Competitive Position

  • Is the company a leader (top 3 in market share in core segments), a challenger, or a fragmented player?
  • What has the company's market share trend been over the last 3–5 years? Is it gaining, holding, or losing?
  • Who are the primary competitors, and are they gaining or losing share to the company?
  • Is the industry consolidating, fragmenting, or stable? How does that affect the company?
  • Are new entrants or disruptors a credible threat to the company's core business?
  • What is the company's differentiation versus competitors—is it defensible, or is it easily copied?
  • Does management have a coherent competitive strategy, or does it seem reactive?

Growth and Disruption

  • What is the company's addressable market, and what percent does it currently serve (TAM, SAM, SOM)?
  • Is the addressable market growing, stable, or shrinking?
  • What are the primary levers of growth (volume, price, new products, expansion into adjacent markets, acquisitions)?
  • For each lever, is growth sustainable, or is it at risk from competition or market saturation?
  • Are there regulatory, technological, or social trends that could disrupt the company's business model?
  • If growth slows materially (from 10% to 3%, for example), would the valuation hold up?

Gate 2: Financial and Valuation Analysis Checklist​

Profitability and Quality

  • Has gross margin been stable, improving, or deteriorating over the last 3–5 years? Is the trend durable?
  • Is operating margin improving because of scale (good) or because of cost-cutting / R&D reduction (risky)?
  • Does operating margin differ materially from peers, and is there a reason (better scale, lower pricing, superior operations)?
  • Is earnings growth pace driven by revenue growth or margin expansion? (Revenue growth is more durable.)
  • Has free cash flow grown in line with reported earnings, or is the divergence widening? (If diverging, which is real?)
  • What is the quality of earnings? Are there one-timers, changes in accounting estimates, or channel stuffing?
  • Have there been material restatements or SEC investigations in the last 10 years?

Balance Sheet and Solvency

  • What is net debt as a multiple of EBITDA? Is it sustainable, or is it rising?
  • What is the debt maturity profile? Are there material refinancing risks in the next 3 years?
  • Is the company's credit rating stable, or is it at risk of upgrade/downgrade?
  • If the company faced a recession and EBITDA fell 30%, would the balance sheet survive without distress?
  • Are there contingent liabilities, off-balance-sheet debt, or pension underfunding that increase leverage?
  • Does the company have adequate liquidity (cash, undrawn revolver, operating cash flow) to cover debt maturities?

DCF and Discount Rate

  • Is the discount rate (WACC) defensible? Can you articulate why this company's WACC differs from peers?
  • Does WACC reflect normalized (not current) interest rates and credit spreads?
  • Is the cost of equity (via CAPM) using beta that reflects forward risk, not just historical correlation?
  • How sensitive is the DCF to WACC? (If a 0.5% change moves fair value >15%, the result is too sensitive.)
  • What is the perpetual growth rate assumption, and is it reasonable (not higher than long-term GDP growth)?
  • What is the terminal value as a percentage of enterprise value? (If >70%, the result depends entirely on an unknowable assumption.)
  • Have you stress-tested the DCF across three scenarios (bear, base, bull) with realistic probability assignments?

Relative Valuation

  • Is the peer set homogeneous (companies with similar growth, profitability, capital structure)?
  • Are there outliers in the peer set that you've excluded or explained?
  • Is the peer average driven by one or two mega-cap outliers, or is it representative of the true set?
  • Have you adjusted peer multiples for growth divergence or profitability divergence? (If not, the comparison is mechanical.)
  • Does the target company's multiple divergence from peers have a narrative explanation? (If not, is it because the explanation is weak?)
  • What is the historical range of the company's multiple (3–5 year range)? How does current multiple sit in that range?

Margin of Safety

  • At what stock price is the margin of safety acceptable (e.g., 20–25% below intrinsic value)?
  • What is the company's intrinsic value range (across scenarios), and what is your confidence in that range?
  • What is the downside scenario value, and how much can the stock drop before you exit?
  • Would you be comfortable holding this stock at a 20% loss while re-evaluating the thesis?

Gate 3: Behavioral and Psychological Checklist​

Thesis Integrity

  • Can you articulate the thesis in one paragraph without hedging or equivocation?
  • What specific facts would prove the thesis wrong? (List 3–5; if you can't, the thesis is unfalsifiable.)
  • Have any of those facts already started to emerge? If yes, is the thesis still valid, or should it be abandoned?
  • How much time have you spent on this thesis? Is your confidence commensurate, or have you fallen in love?
  • If this were someone else's idea, and they presented it to you, what would be your main critique?

Conflicts and Bias

  • Are you invested in the outcome of this analysis (financially, reputationally, or emotionally)?
  • Have you built a 50-page model that would be embarrassing to walk away from? (This is sunk cost bias.)
  • Have you anchored to an initial estimate (price target, fair value) and been unconsciously defending it?
  • Have you been seeking confirming evidence or dismissing contrary evidence?
  • Is management charisma influencing your confidence in the business model? (Ask: What has management actually delivered?)
  • Are you bullish because the market is bullish, or are you doing bottom-up analysis?

Management and Incentives

  • What is management's compensation structure tied to? (EPS growth, revenue, free cash flow, ROIC, long-term equity?)
  • Are management's incentives aligned with creating shareholder value, or with hitting near-term targets?
  • Does management own meaningful stock (>2%)? Did they buy it in the open market or receive it as a grant?
  • Do key executives have material option vesting in the next 12–18 months? If yes, expect near-term-focused decisions.
  • Has management delivered on past promises? (Track record on capex guidance, margin targets, acquisition integration.)
  • Would you trust this management team with your own money, or are you making excuses for them?

Risk and Assumptions

  • What are the three biggest risks to the thesis? Can you articulate them specifically, or are they vague ("execution risk")?
  • How much of the upside is dependent on a "perfect" scenario (macro environment, no competition, no disruption)?
  • What assumption is the valuation most sensitive to? (For most DCF models, it's WACC and terminal growth.)
  • Have you modeled the downside scenario realistically, or have you been too optimistic even in the bear case?
  • What could happen in the next 12 months that would force you to cut losses?

Final Behavioral Gates

  • Can you argue the opposite case (bearish) as persuasively as the bullish case? If not, you haven't thought it through.
  • Is there a chance you're wrong that you're deeply uncomfortable acknowledging?
  • Are you more confident in this thesis than you were 6 months ago? If yes, on what basis?
  • If this stock goes down 25% in the next quarter, would you average down or exit?

Specific Error Screens by Category​

Discount Rate Errors​

  • WACC <5% or >10%? Flag and justify.
  • Perpetual growth rate = long-term risk-free rate or higher? Red flag; terminal value is unreliable.
  • Cost of equity driven more by ERP assumption than by beta? Acknowledge the macro call you're making.
  • WACC unchanged despite a 200 basis point move in bond yields? Re-estimate.

Peer Set Errors​

  • Peer set >15 companies? Question whether you've diluted the comparables.
  • Largest peer >5× the size of smallest peer? Consider sub-grouping by size.
  • Peer set includes companies with >3 percentage point difference in long-term growth rates? Adjust or separate.
  • Peer set includes only public companies? Consider if private comps or precedent transactions strengthen or weaken your set.

Earnings Quality Errors​

  • Operating cash flow materially different from net income? Investigate the gap.
  • Receivables growing >50% faster than revenue? Red flag for revenue recognition issues.
  • Provision for doubtful accounts declining as a % of receivables while growth is rapid? Aggressive provisioning.
  • Non-recurring items or one-timers in the last two years? Adjust normalized earnings.

Growth Assumption Errors​

  • Projecting long-term growth >3% without a clear narrative of market expansion or share gain?
  • Revenue growth assumption for year 10 same as year 3? Consider a more gradual deceleration.
  • Market share assumption implies >30% share gain over 10 years without a moat strengthening mechanism?
  • Projecting margin expansion to levels 200+ basis points above current, without capex support or operating leverage visibility?

Capital Allocation Errors​

  • Company is a serial acquirer but acquisitions have >10% negative returns? Question the next acquisition thesis.
  • Company is buying back stock while leverage is rising? Ask why they're not using cash for debt paydown.
  • Dividend is being paid from operating cash flow but capex is being deferred? Unsustainable.
  • Management is guiding for 5% long-term growth but reinvesting <30% of earnings. Math doesn't work.

Real-World Application: Three Examples​

Example 1: Checking a Bullish Tech Thesis

You're building a bullish thesis on a SaaS company at $80, with a fair value of $120 (50% upside). Run the gates:

Gate 1: Company has 80% recurring revenue, high switching costs. ✓ But customer concentration is high (top 5 = 40% of revenue), and three customers have churned in the last 12 months. ✗ Thesis weakens. Add concentrated customer risk to the model.

Gate 2: WACC is 7.5% based on 5% risk-free rate, 1.0 beta, 5.5% ERP. Terminal growth is 2.5%. Terminal value is 75% of enterprise value. DCF sensitivity: 0.5% change in WACC moves fair value by 18%. Flag as sensitive.

Peer set of 8 companies averages 25× P/E; your company trades at 18×. Peers average 20% growth; your company is 12%. On a PEG basis (P/E / growth), your company is actually more expensive. ✗ Thesis weakens.

Gate 3: You've spent 40 hours building this model. The investment committee is expecting a recommendation. Are you falling in love? Self-check: Can you argue the short case? (Concentrated customers, slowing growth, rising competition from Salesforce.) Yes, fairly well. Can you say which scenario (bull, base, bear) you actually believe in? Base case: 15% growth, 2.5% margin. That feels more realistic than bull (20% growth, 4% margin).

Revised thesis: Company is fairly valued at $80, not cheap. Upside exists, but it's not 50%. Recommendation: Hold, not Buy.

Example 2: Checking a Cyclical Turnaround Thesis

You're building a thesis on a steel company trading at 0.6× book value after a 40% stock decline. Management says: "Capacity utilization is depressed; as volumes recover, margins will expand to 8%."

Gate 1: Capacity utilization is 60%; peers average 75%. Pricing is depressed. The company lost customers to competitors in the last two years. ✗ But the company has the lowest cost structure in the industry (historical advantage). Is that moat sustainable if market share is being lost? Uncertain.

Gate 2: At 8% margins and normalized volumes, earnings would be $3/share and the stock would be "worth" $30 at a normalized 10× P/E. But you're assuming a perfect cycle recovery AND that the company regains lost customers. That's two assumptions, both of which could fail. What's the base case—normalized margins at 5%, or recovery to 8%?

At 5% margins, earnings are $1.87/share, fair value is $18.70. That's a 13% gain from current $16.50. Not compelling when downside to $8 exists if the company loses more share.

Gate 3: You want to believe in the recovery because cycles recover and the stock is "cheap." But are you falling in love with the turnaround narrative? The thesis needs two things to work: cycle recovery (possibly 2–3 years away) AND market share stabilization (far less certain). If either fails, you lose money. Can you live with that?

Recommendation: Pass. The upside/downside doesn't justify the conviction required.

Example 3: Catching a Mistake Before It's Too Late

You're building a bull case on a fintech company. The DCF shows $150 fair value, stock is $100 (50% upside). You're ready to publish.

Before publishing, run Gate 3:

  • What would prove the thesis wrong? "If user growth falls below 30%, if the company loses key partnerships, if competition from incumbents intensifies."
  • Is any of that happening? You check recent news: a key partnership just ended. Market share growth slowed last quarter.
  • Can you defend the thesis in light of these facts? The company says the partnership was "non-core," but it was 15% of revenue.
  • Are you sure, or are you rationalizing? Honest answer: rationalizing.

Walking through Gate 3 catches the error before you publish. You revise the thesis, lower your fair value to $110, or even pass on the stock. Either way, you avoid the mistake.

FAQ​

Q: Should I use this checklist for every stock I analyze?

A: Yes, but with scaling. For a quick screen or sector study, a condensed version (5–10 key questions) suffices. For a full research note or substantial investment, use the full checklist. The gates are your quality control.

Q: What if I fail one of the checklist items? Does that mean I have to abandon the thesis?

A: Not necessarily. But it means you need to acknowledge the risk explicitly and adjust your conviction downward. If peer analysis shows the stock is expensive, the thesis might still be a buy if the business is genuinely superior. But you can't ignore the peer analysis; you have to reconcile it.

Q: Can I shortcut the checklist if I'm confident in the thesis?

A: No. Confidence is exactly when mistakes slip through. The more confident you feel, the more rigorously you should check. Many analysts are most overconfident when they have a compelling narrative and 40 hours of time invested.

Q: How do I tailor the checklist to my own patterns?

A: Track your mistakes. If you've been wrong on leverage in the past, add deeper solvency questions. If you've been bullish on turnarounds that fail, add more skepticism to management narratives. If you've missed disruption, add deeper competitive questions. Personalize the checklist to your weaknesses.

Q: Should the checklist change by company type (tech vs industrials vs consumer)?

A: Slightly. A tech checklist might weight product moats and customer acquisition more heavily. A capital-intensive business checklist might weight capex and leverage more. A consumer business might weight brand and pricing power more. The core framework stays the same; the emphasis shifts.

Q: What if I disagree with the checklist on a specific point?

A: Good. Disagreement means you're thinking. Document why you disagree. "Perpetual growth is 2.8%, above the 2.5% guideline, because TAM expansion will continue for a decade." That's a defensible override. Blind spot: you're overconfident in TAM expansion. Flag it.

  • Decision Frameworks and Bias Reduction — Checklists are a form of decision framework that reduce the influence of emotion and recency on judgment.
  • Pre-Mortems — Before deploying capital, conduct a pre-mortem: imagine the thesis failed catastrophically, then work backward to ask how. This forces consideration of failure modes.
  • Audit Trails and Documented Assumptions — A good checklist includes documenting assumptions so you can revisit and update them, rather than drifting on unconscious assumptions.
  • Gate Testing in Research and Investment — The use of sequential gates (business, financial, behavioral) is standard practice in rigorous research processes and institutional investment workflows.
  • Calibration and Overconfidence — Regular checklist use helps calibrate your confidence. If you're passing 95% of stocks or rejecting 95%, your checklist isn't calibrated.

Summary​

The best analysts don't avoid mistakes; they catch them early through systematic gates. A checklist isn't a substitute for deep thinking; it's a framework that ensures deep thinking happens in critical areas before an error compounds.

The checklist in this article is a template. Adapt it to your specific strengths and weaknesses, your investment style, and the types of companies you analyze. A value investor focused on financial stocks will weight different items than a growth investor focusing on tech. That's fine—personalize.

But the principle is universal: before publishing a research note, pitching an investment, or deploying capital, run through the gates. Business analysis, financial analysis, and behavioral discipline. If the thesis passes all three, you've significantly reduced the risk of a major error.

And if it fails one, you have choices: abandon it, revise it, or explicitly acknowledge the risk and move forward with your eyes open. What you can't do is publish or deploy without having run the gates. That's how mistakes become expensive.

Next​

Read Valuing Apple: a beginner walkthrough to apply this entire framework to a real company in a full, beginner-friendly valuation.

Statistic: Institutional investors who use pre-decision checklists similar to this framework report a 15–25% reduction in material valuation errors and a measurably longer holding period for thesis updates (fewer panic reversals).